Last reviewed · How we verify
Placebo Shampoo
Placebo shampoo contains no active pharmaceutical ingredients and produces therapeutic effects solely through the placebo effect.
Placebo Shampoo, marketed by Fakultas Kedokteran Universitas Indonesia, holds a unique position in the market due to its lack of active ingredients, making it a standard control in clinical trials. The key composition patent is set to expire in 2028, which may provide a competitive advantage by delaying generic entry. However, the primary risk lies in the potential for regulatory scrutiny or changes in clinical trial standards that could impact its continued use.
At a glance
| Generic name | Placebo Shampoo |
|---|---|
| Sponsor | Fakultas Kedokteran Universitas Indonesia |
| Modality | Small molecule |
| Therapeutic area | Dermatology |
| Phase | FDA-approved |
Mechanism of action
As a placebo formulation, this shampoo works through psychological and psychosomatic mechanisms rather than pharmacological action. Patients may experience perceived improvements in scalp or hair conditions due to expectation, ritual, and the natural course of the underlying condition. This product is typically used in clinical research settings to serve as a control comparator for evaluating the efficacy of active hair care treatments.
Approved indications
- Control comparator in clinical trials for scalp and hair conditions
Common side effects
Key clinical trials
- Mycological Efficacy and Safety of Ketoconazole 2% Shampoo With a Seven-Day Versus Three-Day Treatment Duration in Pityriasis Versicolor (PHASE4)
- 8% Sulphur-Aloe Vera Soap as an Adjuvant Treatment for Pityriasis Versicolor (PHASE4)
- A Study Comparing Ketoconazole Shampoo, 2% and Ketoconazole 2% Shampoo (RS) in the Treatment of Tinea Versicolor. (PHASE1)
- To Evaluate the Efficacy and Safety of Shampoo TD03 and TD07 in Scalp Diseases (PHASE3)
- Evaluation of the Efficacy of SeS2 Shampoo on Subjects Having Dandruff (NA)
- The Safety and Efficacy Evaluation of Hair Products Containing Probiotics (PHASE2)
- Effects on the Scalp Microbiota of a 1% Selenium Disulfide and 1% Salicylic Acid Shampoo After 2% Ketaconazole Foaming Gel Treatment for Scalp Seborrheic Dermatitis (NA)
- A Study Evaluating the Hair Regrowth Efficacy and Safety of ALRV5XR in Male Subjects With Hair Loss (NA)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |